WASHINGTON — The Antiviral Drugs Advisory Committee of the Food and Drug Administration recommended the agency approve for preventative use Gilead’s AIDS treatment drug Truvada, according to MSNBC.
Testing has shown promise with high-risk patients in preventing HIV infection when taking the drug daily. Though concerns have been raised over the drug’s cost ($1,200 per month), the possibility for creating drug-resistant strains of the virus and side effects like nausea, HIV prevention specialists welcome the decision as part of a comprehensive toolkit to reducing new infections.
“Existing interventions have not reduced the number of new infections annually and new measures are needed,” Dr. John Mellors, chief of the infectious diseases division at the University of Pittsburgh, told MSNBC.
- Trump makes history with LGBT inclusion in acceptance speech by Chris Johnson | posted on July 22, 2016
- How to talk to gay Republicans by Brock Thompson | posted on July 21, 2016
- Disney star Ross Lynch to portray Jeffrey Dahmer by Mariah Cooper | posted on July 21, 2016
- GOP delegates ratify anti-LGBT platform by Chris Johnson | posted on July 18, 2016
- Cleveland mayor signs transgender rights bill by Michael K. Lavers | posted on July 22, 2016